INBS

Intelligent Bio Solutions Inc.

INBS, USA

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.

https://ibs.inc

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
INBS
stock
INBS

US Market Wrap: Can UHAL stock hit record highs again - Swing Trade & Growth Focused Stock Pick Reports moha.gov.vn

Read more →
INBS
stock
INBS

Intelligent Bio Solutions To Carry Out 1-for-10 Reverse Stock Split On December 16th, 2025 富途牛牛

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$12

Analyst Picks

Strong Buy

1

Buy

0

Hold

0

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

1.32

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-82.38 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-29.72 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-262.39 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

1.83

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 10.66% of the total shares of Intelligent Bio Solutions Inc.

1.

Alyeska Investment Group, L.P.

(6.8369%)

since

2025/06/30

2.

Altium Capital Management, LP

(1.6622%)

since

2025/03/31

3.

Geode Capital Management, LLC

(0.573%)

since

2025/06/30

4.

Fidelity Extended Market Index

(0.3743%)

since

2025/07/31

5.

Vanguard Institutional Extnd Mkt Idx Tr

(0.3465%)

since

2025/07/31

6.

Vanguard Group Inc

(0.1725%)

since

2025/06/30

7.

Goldman Sachs Group Inc

(0.1429%)

since

2025/06/30

8.

Renaissance Technologies Corp

(0.1214%)

since

2025/06/30

9.

Fidelity Series Total Market Index

(0.0996%)

since

2025/07/31

10.

Spartan Extended Market Index Pool F

(0.0762%)

since

2025/07/31

11.

NT Ext Equity Mkt Idx Fd - L

(0.0606%)

since

2025/06/30

12.

Northern Trust Extended Eq Market Idx

(0.0606%)

since

2025/06/30

13.

Fidelity Total Market Index

(0.0456%)

since

2025/07/31

14.

Spartan Total Market Index Pool G

(0.0374%)

since

2025/07/31

15.

Nbc Securities Inc

(0.0262%)

since

2025/06/30

16.

NT Ext Eq Mkt Indx Fd DC Lending Tier 5

(0.0171%)

since

2025/06/30

17.

UBS Group AG

(0.0033%)

since

2025/06/30

18.

Bank of America Corp

(0.0007%)

since

2025/06/30

19.

State St US Extended Mkt Indx NL Cl C

(0.0004%)

since

2025/08/31

20.

SSgA U.S. Total Market Index Strategy

(0.0002%)

since

2025/03/31

21.

NT Ext Eq Mkt Indx Fd DC Lend T3

(0.0001%)

since

2024/12/31

22.

Ground Swell Capital, LLC

(0%)

since

2025/03/31

24.

Tower Research Capital LLC

(0%)

since

2025/03/31

25.

SBI Securities Co Ltd

(0%)

since

2025/06/30

26.

TWO SIGMA SECURITIES, LLC

(0%)

since

2025/03/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

-0.349

EPS Estimate

—

EPS Difference

0

Surprise Percent

null%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(2)
Defensive
Moderately Defensive(4)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
No Clear Moat(2.8)
GARP
Fair GARP(3.5)
Growth
Weak Growth Prospect(3)
Momentum
No Momentum(2)
Net Net
Not Undervalued (Net-Net)(3)
Quality
Low Quality Business(1.5)
Value
Fair Value(3.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.